Ho C - Search Results

1

Impact of Neoadjuvant Chemotherapy on the Administration of Concurrent Chemoradiation for Locally Advanced Nasopharyngeal Carcinoma.

Maas B, Ho C, Hamilton S, Leedy D, Berthelet E. Maas B, et al. Among authors: ho c. Cureus. 2018 Jul 12;10(7):e2971. doi: 10.7759/cureus.2971. Cureus. 2018. PMID: 30280053 Free PMC article.

2

Dose delivery analysis of weekly versus 3-weekly cisplatin concurrent with radiation therapy for locally advanced nasopharyngeal carcinoma (NPC).

Jagdis A, Laskin J, Hao D, Hay J, Wu J, Ho C. Jagdis A, et al. Among authors: ho c. Am J Clin Oncol. 2014 Feb;37(1):63-9. doi: 10.1097/COC.0b013e31826b9b1a. Am J Clin Oncol. 2014. PMID: 23111356

3

Asian Versus Non-Asian Outcomes in Nasopharyngeal Carcinoma: A North American Population-based Analysis.

Hamilton SN, Ho C, Laskin J, Zhai Y, Mak P, Wu J. Hamilton SN, et al. Among authors: ho c. Am J Clin Oncol. 2016 Dec;39(6):575-580. doi: 10.1097/COC.0000000000000091. Am J Clin Oncol. 2016. PMID: 24879476

4

Magnetic Resonance Imaging Volumetry of Primary Nasopharyngeal Cancer in Patients Treated with Induction Gemcitabine and Cisplatin Followed by Concurrent Cisplatin and Volumetric Modulated Arc Therapy.

Giambattista J, McVicar N, Hamilton S, Martin M, Maas B, Ho C, Wu J, Tran E, Hay J, Berthelet E. Giambattista J, et al. Among authors: ho c. Cureus. 2018 Sep 13;10(9):e3296. doi: 10.7759/cureus.3296. Cureus. 2018. PMID: 30443466 Free PMC article.

5

Palliative thoracic radiotherapy near the end of life in lung cancer: A population-based analysis.

Fraser I, Lefresne S, Regan J, Berthelet E, Chooback N, Ho C, Olson R. Fraser I, et al. Among authors: ho c. Lung Cancer. 2019 Sep;135:97-103. doi: 10.1016/j.lungcan.2019.02.024. Epub 2019 Feb 22. Lung Cancer. 2019. PMID: 31447009

6

Treatment for Recurrent Differentiated Thyroid Cancer: A Canadian Population Based Experience.

Shokoohi A, Berthelet E, Gill S, Prisman E, Sexsmith G, Tran E, White A, Wiseman SM, Wu J, Ho C. Shokoohi A, et al. Among authors: ho c. Cureus. 2020 Feb 27;12(2):e7122. doi: 10.7759/cureus.7122. Cureus. 2020. PMID: 32257668 Free PMC article.

7

Patient-reported outcome measures in patients undergoing radiotherapy for head and neck cancer.

Hamilton SN, Tran E, Ho C, Berthelet E, Wu J, DeVries K, LaPointe V, Bowman A, Lagman M, Olson R. Hamilton SN, et al. Among authors: ho c. Support Care Cancer. 2021 May;29(5):2537-2547. doi: 10.1007/s00520-020-05778-2. Epub 2020 Sep 19. Support Care Cancer. 2021. PMID: 32949298

8

Comparison of 2-Weekly Versus 4-Weekly Durvalumab Consolidation for Locally Advanced NSCLC Treated With Chemoradiotherapy: A Brief Report.

Denault MH, Kuang S, Shokoohi A, Leung B, Liu M, Berthelet E, Laskin J, Sun S, Zhang T, Melosky B, Ho C. Denault MH, et al. Among authors: ho c. JTO Clin Res Rep. 2022 Mar 30;3(5):100316. doi: 10.1016/j.jtocrr.2022.100316. eCollection 2022 May. JTO Clin Res Rep. 2022. PMID: 35498385 Free PMC article.

9

Beyond PACIFIC: Real-World Outcomes of Adjuvant Durvalumab According to Treatment Received and PD-L1 Expression.

Denault MH, Feng J, Kuang S, Shokoohi A, Leung B, Liu M, Berthelet E, Laskin J, Sun S, Zhang T, Ho C, Melosky B. Denault MH, et al. Among authors: ho c. Curr Oncol. 2023 Aug 8;30(8):7499-7507. doi: 10.3390/curroncol30080543. Curr Oncol. 2023. PMID: 37623024 Free PMC article.

10

Cetuximab in locally advanced head-and-neck cancer: defining the population.

Ho C. Ho C. Curr Oncol. 2010 Aug;17(4):48-51. doi: 10.3747/co.v17i4.696. Curr Oncol. 2010. PMID: 20697514 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,965 results

Search Page

Filters